← Back to Search

Behavioral Intervention

Resilience Training for Mental Health

N/A
Recruiting
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before the intervention, 6 weeks later, and 6 months later
Awards & highlights
No Placebo-Only Group

Summary

This trial aimed to see if teaching resilience skills using virtual reality technology is practical and well-received by participants.

Who is the study for?
The ROOM trial is for college students aged 18-30 enrolled in undergraduate programs and healthcare providers over 18 who work with patients. Participants must speak English well and not be in frequent psychotherapy. Those with acute psychiatric symptoms, current suicidality, or serious substance issues cannot join.
What is being tested?
This study tests the effectiveness of Resilience Training delivered through virtual reality to help individuals cope better with stressors related to psychosis, anxiety, and mood disorders.
What are the potential side effects?
Since this trial involves psychological resilience training rather than medication, traditional side effects are not expected; however, participants may experience discomfort or emotional distress during the process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before the intervention, 6 weeks later, and 6 months later
This trial's timeline: 3 weeks for screening, Varies for treatment, and before the intervention, 6 weeks later, and 6 months later for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Discomfort with Others
Intervention Feasibility and Acceptability
Penn Emotion Recognition Test
+1 more
Secondary study objectives
Beck Depression Inventory
Connor-Davidson Resilience Scale
Prodromal Questionnaire- Brief
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Resilience TrainingExperimental Treatment1 Intervention
A 6 1-hour session group based intervention to deliver mindfulness, metallization, and self-compassion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resilience Training
2018
N/A
~110

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,005 Previous Clinical Trials
13,309,616 Total Patients Enrolled
47 Trials studying Schizophrenia
7,306 Patients Enrolled for Schizophrenia
~10 spots leftby Jan 2025